Sign in to view content

Potential Safety Concerns of Bevacizumab for Retinopathy of Prematurity

Robert L. Avery, MD

Video
Published 2016

Related

Higher-Order Optical Coherence Tomography Fluid Burden Assessment: Analysis From the OSPREY Trial
Justis P. Ehlers, MD, FASRS
Annual Meeting Talks
2019
First Results From a Phase 1B Multiple-Dose Study of KSI-301: A Novel Anti-VEGF Antibody Biopolymer Conjugate (ABC) With Extended Durability
Pravin U. Dugel, MD
Annual Meeting Talks
2019
Tricks of Anti-VEGF Treatment for Retinopathy of Prematurity: How and when to Do It? When to Wait? When to Redo?
HUSEYIN YETIK, MD, PROFESSOR OF OPHTHALMOLGY
On Demand Cases, Courses, and Papers
2019

Category: Pediatric Retina

See more